Form 4 for MPLT MapLight Therapeutics, Inc.
Accepted 2026-04-17 16:05:20 ET · period of report 2026-04-15 · accession 0001709954-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 16:05 | 2026-04-15 | MPLT | GILLIS JONATHAN | CAAO, PAO | S - Sale | $26.61 | -3,590 | 251.1K | -1% | -$95.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2026-04-15 | S | D | 3,590 | $26.61 | 251,054 | D | — | — | (F1) Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6045 to $26.6093 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes 121 shares acquired under the Issuer's stock purchase plan on March 31, 2026. |